GlassScriptPhysician profile
Samir E Ruvinov
NPI 1235294257
$1,434.91
in general payments reported to CMS, 2019-2025
11 companies · $113 in 2025
The $113 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $23.81 · 2021: $633 · 2023: $160 · 2024: $266 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $477 · Gift: $62.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $476.58 |
| Gift | $62.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $656.13 | 2020-2024 | |
| Align Technology, INC. | $345.90 | 2019-2025 | Invisalign, Itero Element 5d Plus |
| Tulsa Dental Products LLC | $131.14 | 2019 | |
| Patterson Companies, INC. | $96.93 | 2025 | |
| Dentsply Sirona INC | $66.67 | 2019-2023 | Waveone Gold Conform Fit |
| Ultradent Products INC | $62.49 | 2024 | Opalescence |
| Nobel Biocare USA | $29.48 | 2023 | Nobelactive |
| Biohorizons Implant Systems INC. | $15.89 | 2024 | Biohorizons |
| Colgate Oral Pharmaceuticals, INC. | $13.30 | 2023 | |
| Voco America INC. | $10.48 | 2020 | |
| Kettenbach LP | $6.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Ruvinov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.